MedTrace Logo

Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS

NCT06505941 · Status: NOT_YET_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-07-17

No results posted yet for this study

Summary

The object of this study is to observe the safety of umbilical cord mesenchymal stem cell therapy for acute respiratory distress syndrome, consisting with two phases.

Conditions

  • Acute Respiratory Distress Syndrome

Interventions

DRUG

umbilical cord mesenchymal stem cell

umbilical cord mesenchymal stem cell

DRUG

Placebo

non-cell-containing placebo

Sponsors & Collaborators

  • Zhongda Hospital

    collaborator OTHER

  • Yinguan Biologics, Shenzheng

    collaborator UNKNOWN

  • Southeast University, China

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-20
Primary Completion
2025-11-20
Completion
2027-02-20

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06505941 on ClinicalTrials.gov